Announcements Trials
Browse Landscape

Status

Recruiting 4Completed 2Available 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Endocrine 2Sarcoma 1NET 1

Conditions

Pheochromocytoma 2Neuroblastoma 2Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Recurrence 1Paraganglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Fibrosarcoma 1Congenital Hyperinsulinism 1Beckwith-Wiedemann Syndrome 1Adenoma, Islet Cell 1

Interventions

fluorodopa F 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Hyperinsulinism × Endocrine × Clear all
NCT01916148 2026-04-27

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Children's Hospital of Philadelphia

Available
Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡